HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Commentary: The response and survival of children with recurrent diffuse intrisic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma, by Burzynski G, et al.

AuthorsMaura Massimino, Carlo Alfredo Clerici
JournalChild's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery (Childs Nerv Syst) Vol. 30 Issue 12 Pg. 2065-6 (Dec 2014) ISSN: 1433-0350 [Electronic] Germany
PMID25079885 (Publication Type: Clinical Trial, Phase II, Journal Article)
Chemical References
  • Benzeneacetamides
  • Drug Combinations
  • Phenylacetates
  • Piperidones
  • Glutamine
  • antineoplaston AS 2-1
  • antineoplaston A10
Topics
  • Adolescent
  • Antineoplastic Combined Chemotherapy Protocols (adverse effects, therapeutic use)
  • Benzeneacetamides (adverse effects, therapeutic use)
  • Biomedical Research (standards)
  • Brain Stem Neoplasms (drug therapy, mortality)
  • Child
  • Child, Preschool
  • Disease Progression
  • Drug Combinations
  • Female
  • Glioma (drug therapy, mortality)
  • Glutamine (adverse effects, analogs & derivatives, therapeutic use)
  • Humans
  • Infusions, Intravenous
  • Male
  • Neoplasm Recurrence, Local (drug therapy, mortality)
  • Phenylacetates (adverse effects, therapeutic use)
  • Piperidones (adverse effects, therapeutic use)
  • Pons
  • Prognosis
  • Survival Rate
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: